ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Scope & Guideline

Championing evidence-based practices in Alzheimer’s research.

Introduction

Welcome to the ALZHEIMER DISEASE & ASSOCIATED DISORDERS information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of ALZHEIMER DISEASE & ASSOCIATED DISORDERS, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN0893-0341
PublisherLIPPINCOTT WILLIAMS & WILKINS
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1987 to 2024
AbbreviationALZ DIS ASSOC DIS / Alzheimer Dis. Assoc. Dis.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103

Aims and Scopes

The journal 'Alzheimer Disease & Associated Disorders' focuses on advancing the understanding of Alzheimer’s disease and related disorders. It aims to publish high-quality research that covers a wide spectrum of topics related to cognitive decline, dementia, and the various factors affecting these conditions.
  1. Cognitive Function and Dementia Assessment:
    Research that explores various methodologies for assessing cognitive function, including neuropsychological tests and imaging techniques, to better understand dementia progression.
  2. Biomarkers and Pathophysiology:
    Studies focusing on identifying biomarkers for Alzheimer's disease and related disorders, as well as understanding the underlying biological mechanisms contributing to neurodegeneration.
  3. Impact of Lifestyle and Environmental Factors:
    Investigations into how lifestyle choices, such as physical activity and diet, as well as environmental factors, influence cognitive health and the risk of dementia.
  4. Caregiver Studies and Psychosocial Aspects:
    Research examining the burden and quality of life for caregivers of Alzheimer’s patients, and the psychosocial impacts of dementia on individuals and families.
  5. Clinical Interventions and Therapeutics:
    Studies investigating various therapeutic approaches, including pharmacological and non-pharmacological interventions, aimed at managing or treating Alzheimer’s disease and related disorders.
  6. Diversity and Health Disparities:
    Research that highlights the differences in Alzheimer’s disease prevalence and outcomes among diverse populations, addressing health disparities in care and access.
Recent publications in 'Alzheimer Disease & Associated Disorders' reveal several emerging themes that reflect the evolving landscape of research in the field. These trends indicate areas of growing interest and relevance.
  1. Holistic and Multidisciplinary Approaches:
    There is an increasing trend towards studies that incorporate multidisciplinary perspectives, including psychological, social, and environmental factors in understanding and managing Alzheimer’s disease.
  2. Prevention and Early Intervention Strategies:
    Research focused on identifying early signs of cognitive decline and implementing preventive strategies is gaining prominence, highlighting the importance of early detection and intervention.
  3. Technology in Dementia Care:
    The use of technology, including digital health tools and telemedicine, in dementia care and research is on the rise, reflecting a shift towards innovative solutions for patient management and research methodologies.
  4. Cultural and Ethnic Studies in Dementia:
    Emerging research is increasingly examining the cultural and ethnic dimensions of dementia care, addressing how cultural factors influence perceptions, diagnosis, and treatment of Alzheimer’s disease.
  5. Neuropsychiatric Symptoms and Behavioral Interventions:
    There is heightened interest in exploring neuropsychiatric symptoms associated with dementia and the development of behavioral interventions to manage these symptoms effectively.

Declining or Waning

While the journal continues to explore a wide range of topics, some areas have shown a decline in focus over recent years. These waning themes may reflect shifts in research priorities or emerging interests in the field.
  1. Genetic Studies in Alzheimer’s Disease:
    Although genetic research remains important, the frequency of publications focusing solely on genetic variants related to Alzheimer’s has decreased, possibly due to a saturation of findings and a shift towards integrative approaches that consider environmental and lifestyle factors.
  2. Animal Models in Alzheimer Research:
    There has been a noticeable decline in studies exclusively using animal models to investigate Alzheimer’s disease, indicating a potential shift towards human-centric research and clinical studies.
  3. Traditional Pharmacological Approaches:
    The focus on traditional pharmacological treatments for Alzheimer’s disease is waning as researchers increasingly explore alternative and complementary therapies, including lifestyle interventions and holistic approaches.

Similar Journals

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Exploring the frontiers of brain health and mental wellness.
Publisher: BMJ PUBLISHING GROUPISSN: 0022-3050Frequency: 12 issues/year

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, published by the esteemed BMJ PUBLISHING GROUP, is a leading journal that covers pivotal research in the fields of neurology, neurosurgery, and psychiatry. With an impressive impact factor and consistently recognized as a Q1 journal in its respective categories—including Clinical Neurology, Psychiatry and Mental Health, and Surgery—this publication ranks in the top percentiles on Scopus, showcasing its influence in the medical community. Since its inception in 1920, the journal has been committed to delivering high-quality, peer-reviewed content to researchers, clinicians, and students alike, maintaining an exceptional reputation attributed to its rigorous selection process and the depth of its contributions. Access to the journal's articles fosters a comprehensive understanding of progressive research and clinical practices, solidifying its significance for professionals aiming to navigate the complexities of neurological and psychiatric disorders. As a vital resource based in the United Kingdom, the journal continues to propel innovation and knowledge sharing in the ever-evolving landscape of neurohealth.

Biological Psychiatry-Cognitive Neuroscience and Neuroimaging

Advancing Insights in Mental Health through Neuroimaging
Publisher: ELSEVIERISSN: 2451-9022Frequency: 12 issues/year

Biological Psychiatry-Cognitive Neuroscience and Neuroimaging is a leading interdisciplinary journal published by Elsevier, focusing on the convergence of biological psychiatry, cognitive neuroscience, and advanced neuroimaging techniques. With its prestigious Q1 rankings across essential categories such as Biological Psychiatry, Cognitive Neuroscience, and Neurology (clinical), this journal is at the forefront of research that examines the complexities of mental health through innovative methodologies. Covering a broad spectrum of topics from neurobiological mechanisms to clinical applications, it aims to provide a platform for scholars and practitioners to exchange insights on mental disorders and their neurobiological underpinnings. The impact factor and Scopus rankings further underscore its importance, with rankings highlighting its position in the top percentiles of related disciplines. By fostering an open exchange of ideas and promoting cutting-edge research, this journal is an essential resource for researchers, professionals, and students dedicated to advancements in the understanding and treatment of psychiatric and neurological conditions.

JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY

Advancing knowledge in aging and mental health.
Publisher: SAGE PUBLICATIONS INCISSN: 0891-9887Frequency: 6 issues/year

JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, published by SAGE PUBLICATIONS INC, is a premier academic journal dedicated to advancing the understanding of mental health issues and neurological disorders in the aging population. With an established presence since 1988, this journal stands out in the fields of Geriatrics, Gerontology, Neurology, and Psychiatry, currently positioned in the Q2 category based on 2023 metrics, reflecting its influence and academic rigor. The journal is indexed in major databases and is highly regarded for its contributions, as evidenced by its strong Scopus rankings. It serves as an essential resource for researchers, clinicians, and students, offering insightful articles that explore the complex interplay between aging, mental health, and neurological conditions. Although it does not provide open access, it continues to be a vital source of scholarly knowledge for those dedicated to enhancing the well-being of the elderly population.

NEUROBIOLOGY OF AGING

Unraveling the Mysteries of Aging and the Brain
Publisher: ELSEVIER SCIENCE INCISSN: 0197-4580Frequency: 6 issues/year

NEUROBIOLOGY OF AGING, published by Elsevier Science Inc, is a premier journal dedicated to advancing our understanding of the complex interactions between the aging process and neurobiological mechanisms. With an ISSN of 0197-4580 and E-ISSN 1558-1497, the journal has established itself as a critical resource in the fields of Aging, Developmental Biology, Geriatrics and Gerontology, Clinical Neurology, and Neuroscience. Boasting a Q1 ranking in multiple categories, the journal is positioned within the top echelons of scholarly publication, underscoring its significant impact with an impressive Scopus ranking in various subfields. Committed to disseminating high-quality, peer-reviewed research, NEUROBIOLOGY OF AGING welcomes original articles, reviews, and research notes aiming to uncover the underlying processes of aging on the nervous system, fostering collaboration among researchers, professionals, and students alike. Although primarily subscription-based, the journal continues to play a vital role in shaping the discourse on aging and neurobiology, making it an essential publication for those engaged in this dynamic field.

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Bridging research and practice in geriatric cognitive care.
Publisher: KARGERISSN: 1420-8008Frequency: 6 issues/year

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS is a distinguished peer-reviewed journal published by KARGER, based in Switzerland. With a focus on the critical fields of cognitive neuroscience, geriatrics, and psychiatry, this journal is integral to advancing our understanding of cognitive decline and geriatric health. Despite being established from 1990 through 1992 and relaunching its scope in 1994, it has consistently provided a platform for innovative research, as reflected in its strong impact factor and notable Scopus rankings, placing it in the Q2 quartile for disciplines including cognitive neuroscience and geriatric medicine. The journal aims to foster interdisciplinary dialogue and collaboration among researchers, healthcare professionals, and educators, contributing to the growing field of dementia research and elderly care. Open access options further ensure that this vital knowledge is widely accessible, making a significant impact in both academic and clinical settings. With a commitment to quality and relevance, DEMENTIA AND GERIATRIC COGNITIVE DISORDERS remains a key resource for those dedicated to understanding and addressing the challenges posed by cognitive disorders in aging populations.

JOURNAL OF ALZHEIMERS DISEASE

Empowering professionals with cutting-edge research.
Publisher: IOS PRESSISSN: 1387-2877Frequency: 24 issues/year

Journal of Alzheimer's Disease, published by IOS Press, stands as a pivotal resource in the fight against Alzheimer's and related neurodegenerative disorders. With an ISSN of 1387-2877 and an E-ISSN of 1875-8908, this esteemed journal has evolved since its inception in 1998, providing a vital platform for academic research and clinical practice in the realms of Clinical Psychology, Geriatrics and Gerontology, Neuroscience, and Psychiatry and Mental Health. Ranked in the Q1 category across several disciplines, including Clinical Psychology and Geriatrics, this journal not only highlights significant advancements in understanding Alzheimer's disease but also fosters interdisciplinary dialogue among researchers, healthcare professionals, and policymakers. Boasting robust Scopus rankings—such as 49th in Clinical Psychology and 29th in Geriatrics—this journal is committed to disseminating high-quality research that informs both therapeutic strategies and public health initiatives. The Journal of Alzheimer's Disease is an essential resource for anyone dedicated to exploring the complexities of cognitive decline and enhancing care for affected individuals.

Journal of Alzheimers Disease Reports

Elevating the Discourse on Cognitive Disorders
Publisher: IOS PRESSISSN: Frequency: 1 issue/year

Journal of Alzheimer's Disease Reports, published by IOS PRESS, is an essential open-access platform dedicated to advancing research in the fields of clinical psychology, geriatrics, gerontology, neuroscience, and psychiatry. Since its inception in 2017, this journal has rapidly gained recognition, achieving a commendable status reflected in its 2023 category quartiles, notably ranking Q2 in Clinical Psychology and Psychiatry and Mental Health. With a sustained commitment to disseminating high-quality research and facilitating collaboration among scientists, the journal offers insights into the critical aspects of Alzheimer's disease and related cognitive disorders. Given its positions in the Scopus ranks, it serves as a crucial resource for academics and practitioners alike, empowering them to contribute effectively to the ongoing discourse in cognitive health. The journal embraces open access, ensuring that all research findings are freely available to the global community, thereby enhancing visibility and engagement. With a focus on fostering innovation and knowledge transfer, Journal of Alzheimer's Disease Reports is poised to make an enduring impact in the field of dementia research.

npj Aging

Bridging research and policy for a healthier aging society.
Publisher: NATURE PUBL GROUPISSN: Frequency: 1 issue/year

npj Aging, published by Nature Publishing Group, is a pioneering journal dedicated to advancing our understanding of the biological, clinical, and social aspects of aging. With an E-ISSN of 2731-6068, this open-access journal aims to foster innovative research and interdisciplinary dialogue among scientists, clinicians, and policy-makers. As of its inception in 2023, the journal has quickly established itself within the scholarly community, ranking 15th in Medicine (Geriatrics and Gerontology) and 12th in Biochemistry, Genetics, and Molecular Biology focusing on Aging, reflecting a strong percentile standing in both categories. The journal provides a platform for disseminating important findings that address the complexities of aging, ensuring accessibility for a broader audience. Located at the Macmillan Building, 4 Crinan St, London, England, npj Aging aspires to be an essential resource for those seeking to enhance their understanding and contribute to the field of gerontology.

JPAD-Journal of Prevention of Alzheimers Disease

Exploring Breakthroughs in Neurology and Mental Health
Publisher: SPRINGER BASEL AGISSN: 2274-5807Frequency: 4 issues/year

JPAD - Journal of Prevention of Alzheimer’s Disease, published by Springer Basel AG, is a premier academic journal dedicated to advancing research in the critical field of Alzheimer’s disease prevention. Its impactful contributions to the fields of neurology, psychiatry, and mental health have led it to achieve a Q1 ranking in multiple categories, including neurology (clinical) and psychiatry and mental health. Since its inception in 2017, JPAD has become an essential platform for researchers and professionals aiming to stay at the forefront of developments in Alzheimer’s disease research, prevention strategies, and innovative therapies. The journal provides a valuable open access option for disseminating high-quality research to a global audience, enhancing its visibility and impact. With its strategic focus and rigorous peer-review process, JPAD is committed to fostering collaboration and knowledge exchange among scientists, clinicians, and practitioners, ultimately contributing to the global effort to combat Alzheimer's disease.

AGING & MENTAL HEALTH

Advancing Knowledge in Geriatric Psychology
Publisher: ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTDISSN: 1360-7863Frequency: 12 issues/year

AGING & MENTAL HEALTH, published by Routledge Journals, Taylor & Francis Ltd, is a leading academic journal that focuses on the dynamic intersection of aging and mental health, critically addressing issues pertinent to geriatric psychology and psychiatry. Established in 1997, this journal covers a wide range of topics including mental health disorders in older populations, cognitive decline, and social implications of aging. With an impressive reputation, it currently ranks in the Q1 category in Geriatrics and Gerontology, Gerontology, and Psychiatry and Mental Health, showcasing its significant contribution to these fields. The journal is recognized for its high-quality, peer-reviewed research and holds esteemed positions in Scopus rankings, emphasizing its relevance and impact in psychiatric nursing and gerontology. While it does not offer open access, AGING & MENTAL HEALTH remains a vital resource for researchers, professionals, and students dedicated to advancing our understanding of mental health in the aging population.